Induction of apoptosis in the human mast cell leukemia cell line HMC-1 by various antineoplastic drugs

Leukemia and Lymphoma

Volumn 44, Issue 3, 2003, Pages 509-515

  Samorapoompichit, Puchit ^a,b   Steiner, Marianne ^a   Lucas, Trevor ^a   Wachtler, Franz ^a   Schedle, Andreas ^a   Sperr, Wolfgang R ^b   Valent, Peter ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Apoptosis; HMC 1; Mast cells; Mastocytosis; Necrosis

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CLADRIBINE; CYTARABINE; CYTOSTATIC AGENT; CYTOTOXIC AGENT; DNA FRAGMENT; DOXORUBICIN; ENDONUCLEASE; ETOPOSIDE; FLUDARABINE; THYMIDINE; TRITIUM; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENCY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKEMIA CELL LINE; MAST CELL LEUKEMIA; NICK END LABELING; PRIORITY JOURNAL; REVIEW;

2-CHLOROADENOSINE; ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; CYTARABINE; DEOXYADENOSINES; DNA FRAGMENTATION; DOXORUBICIN; ENDODEOXYRIBONUCLEASES; ETOPOSIDE; HUMANS; IN SITU NICK-END LABELING; LEUKEMIA, MAST-CELL; MICROSCOPY, ELECTRON; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED; VIDARABINE; VINCRISTINE;

EID: 0037344906     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819021000046976     Document Type: Review

References (21)

1. Lennert, K. and Parwaresch, M.R. (1979) "Mast cells and mast cell neoplasia a review", Histopathology 3, 349-365.
2. Metcalfe, D.D. (1991) "Classification and diagnosis of mastocytosis: current status", Journal of Investigative Dermatology 96, 2S-4S.
3. Valent, P, Horny, H.P., Escribano, L., Longley, J.B., Li, C.Y., Schwartz, L.B., Marone, G., Nunez, R., Akin, C., Sotlar, K., Sperr, W.R., Wolff, K., Brunning, R.D., Parwaresch, M.R., Austen, K.F., Lennert, K., Metcalfe, D.D., Vardiman, J.W. and Bennett, J.M. (2001) "Diagnostic criteria and classification of mastocytosis: a consensus proposal", Leukemia Research 25, 603-625.
4. Parwaresch, M.R., Horny, H.-P. and Lennert, K. (1985) "Tissue mast cells in health and disease", Pathology Research and Practice 179, 439-461.
5. Lawrence, J.B., Friedman, B.S., Travis, W.D., Chinchilli, V.M., Metcalfe, D.D. and Gralnick, H.R. (1991) "Hematologic manifestation of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis", American Journal of Medicine 91, 612-624.
6. Travis, W.D., Li, C.Y., Hoagland, H.C., Travis, L.B. and Banks, P.M. (1986) "Mast cell leukemia: report of a case and review of the literature", Mayo Clinical Proceedings 61, 957-966.
7. Butterfield, J.H., Weiler, D., Dewald, G. and Gleich, G.J. (1988) "Establishment of an immature mast cell line from a patient with mast cell leukemia", Leukemia Research 12, 345-355.
8. Kluin-Nelemans, H.C., Jansen, J.H., Breukelman, H., Wolthers, B.G., Klunin, P.M., Kroon, H.M. and Willemze, R. (1992) "Response to interferon alpha-2b in a patient with systemic mastocytosis", New England Journal of Medicine 326, 619-623.
9. Worobec, A.S. (2000) "Treatment of systemic mast cell disorders", Hematology and Oncology in North America 14, 659-687.
10. Butterfield, J.H. and Weiler, D.A. (1989) "In vitro sensitivity of immature human mast cells to chemotherapeutic agents", International Archives of Allergy and Immunology 89, 297-300.
11. Sillaber, C., Strobl, H., Bevec, D., Ashman, L.K., Butterfield, J.H., Lechner, K., Maurer, D., Bettelheim, P. and Valent, P. (1991) "IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells", Journal of Immunology 147, 4224-4228.
12. Schedle, A., Samorapoompichit, P, Rausch-Fan, X.H., Franz, A., Fureder, W., Sperr, WR., Sperr, W., Ellinger, A., Slavicek, R., Boltz-Nitulescu, G. and Valent, P. (1995) "Response of L-929 fibroblasts, human gingival fibroblasts, and human tissue mast cells to various metal cations", Journal of Dental Research 8, 1513-1520.
13. Gorczyca, W., Gong, J. and Darzynkiewicz, Z. (1993) "Detection of strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidal transferase and nick translation assays", Cancer Research 53, 1945-1951.
14. Walker, P.R., Carson, C., Leblanc, J. and Sikorska, M. (2002) "Labeling DNA damage with terminal transferase. Applicability, specificity, and limitations", Methods in Molecular Biology 203, 3-19.
15. Keating, M.J., O'Brien, S., McLaughlin, P, Dimopoulos, M., Gandhi, V., Plunkett, W., Lerner, S., Kantarjian, H. and Estey, E. (1996) "Clinical experience with fludarabine in hemato-oncology", Hematology and Cell Therapy 38, 83-91.
16. Johnson, S.A. (2001) "Nucleoside analogues in the treatment of haematological malignancies", Expert Opinion in Pharmacotherapy 2, 929-943.
17. Tefferi, A., Li, C.Y, Butterfield, J.H. and Hoagland, H.C. (2001) "Treatment of systemic mast cell disease with cladribine", New England Journal of Medicine 344, 307-309.
18. Solary, E., Plenchette, S., Sordet, O., Rebe, C., Ducoroy, P., Filomenko, R., Bruey, J.M., Droin, N. and Corcos, L. (2001) "Modulation of apoptotic pathways triggered by cytotoxic agents", Therapie 56, 511-518.
19. Duvall, E. and Wyllie, A.H. (1986) "Death and the cell", Immunology Today 7, 115-119.
20. Wyllie, A.H., Duvall, E. and Blow, J.J. (1984) "Intercellular mechanisms in cell death in normal and pathological tissues", Cell Aging and Cell Death (Cambridge University Press, Cambridge), pp. 269-294.
21. Gottesman, M.M. (2002) "Mechanisms of cancer drug resistance", Annual Review of Medicine 53, 615-627.